US Administration Policies & Priorities

The new administration's policies will have significant short- and long-term implications for businesses and organizations across all industries—in the United States and around the world.

As the administration’s policies and priorities are put into action, our cross-disciplinary, bipartisan team of lawyers is monitoring developments for clients and companies that may be impacted. In this space, we offer resources to bring you the latest on executive orders, tariffs, and other executive or agency actions. View our thought leadership, webinars, and other resources below, and come back often for the newest developments.

Executive Orders

Our legal team is closely monitoring executive orders and updates from the White House. Below are resources to help navigate the US administration’s executive orders—including their scope, potential implications, and tips on how to prepare.

Blog Post
US Administration’s Executive Orders and Actions’ Impact on Group Health Plans
These EOs provide insight into the US administration’s policies and outline potential actions that regulatory agencies and Congress may take to implement these policies.
Learn more
LawFlash
President Trump Issues Executive Order Temporarily Pausing FCPA Enforcement
Less than one month into the second Trump administration, it seems clear that—at least through 2028—there will be a significant shift in the DOJ’s approach to corporate anti-corruption enforcement.
Learn more
LawFlash
Executive Actions Substantially Revise Environmental Justice Policies and Practices
The early executive actions have rescinded environmental justice initiatives dating back more than 30 years as a part of the US administration’s broader objective of eliminating considerations of race, ethnicity, and diversity from the federal government.
Learn more
LawFlash
How New Executive Orders May Affect FDA’s Medical Device Operations
The executive orders may delay pending regulations, create uncertainty for FDA’s prior guidance related to artificial intelligence, and adversely impact FDA staffing and resources.
Learn more
LawFlash
Executive Order Aims to Strengthen US Leadership in Digital Financial Technology
The executive order outlines the new administration’s commitment to strengthening US leadership in the digital asset space, and contains policies that seek to foster regulatory clarity for digital assets, among other items.
Learn more
Tariffs

As the Trump-Vance economic plan takes shape, tariffs are at the forefront of proposed action. Here we provide the latest on the administration’s anticipated trade strategy and its potential impacts—and strategies to prepare.

All Insights

LawFlash
US Designation of Cartels as Terrorist Organizations Increases Risk of Doing Business in Mexico
Recent US government actions indicate a possible increase in US financial crimes investigations and enforcement targeting drug cartels and transnational criminal organizations in Latin America.
Learn more
LawFlash
EEOC and DOJ Issue Guidance on Discrimination Related to DEI under Title VII
The guidance documents provide welcome clarity to employers regarding the types of employment programs that the new administration believes may constitute “illegal DEI” under federal law.
Learn more
Blog Post
US Administration’s Executive Orders and Actions’ Impact on Group Health Plans
These EOs provide insight into the US administration’s policies and outline potential actions that regulatory agencies and Congress may take to implement these policies.
Learn more
LawFlash
SEC Commissioner Calls for Public Input on Crypto Asset Regulation
The statement invites digital asset industry participants to engage with the SEC’s Crypto Task Force and help shape a more predictable crypto asset regulatory environment.
Learn more
LawFlash
The State of FARA Following Attorney General Bondi’s Reprioritization of DOJ Resources
The memorandum General Policy Regarding Charging, Plea Negotiations, and Sentencing, among other changes, directs DOJ’s National Security Division to deprioritize criminal enforcement of the Foreign Agents Registration Act.
Learn more

How We Can Help

Our team stands ready to guide clients through the full spectrum of current and future issues. If you have any questions or need assistance, please reach out to any of the lawyers pictured below in the contacts section or your regular Morgan Lewis contact.

Our team’s extensive knowledge spans the spectrum of competition law—from obtaining global pre-merger approval of competitive transactions, to responding to investigations by government authorities and defending class action and competitor lawsuits, to advising on issues involving intellectual property, competitor collaborations, and other antitrust matters.

We have briefed, argued, and won many cases before the US Supreme Court, every US Circuit Court of Appeals, and numerous state appellate courts. We also maintain an active amicus curiae practice, filing briefs on behalf of market leaders, industry groups, and members of Congress in federal and state courts across the United States.

Clients turn to Morgan Lewis as they address how climate change impacts their businesses and communities—whether through reducing their carbon footprints, securing tax benefits, or implementing an environmental, social, and governance (ESG) strategy.

With many of our lawyers returning to Morgan Lewis after serving in the highest levels of government, we maintain strong relationships with government agencies and regulators. Our bipartisan congressional investigations team routinely represents clients before a wide range of Senate and House committees, subcommittees, and offices.

Our team of former senior Department of Justice (DOJ) officials understands the nuances of corporate criminal investigations. When there is new DOJ leadership, we assist clients in navigating policy and personnel changes in an agency whose actions have been a topic of significant discussion during the campaign.

Our adept FDA and healthcare team advises clients on compliance with federal and state laws governing health products (drugs, biologics, and devices) and healthcare services, including enforcement actions, regulatory advice, and policy changes from HHS, CMS, FDA, DEA, and other agencies. We assist clients in navigating regulatory agency actions, including enforcement actions, and advise on evolving regulatory standards and strategies.

Our global financial services lawyers regularly represent many of the largest financial institutions in the United States in high-stakes litigation and government investigations. We also assist clients in avoiding potential litigation by performing internal investigations, communicating with government agencies, and developing robust and compliant business procedures.

We advise clients on cross-border projects involving employees and workplace laws in North America, Asia, Latin America, Europe, and the Middle East. Our full-service team helps multinational employers manage their global workforces in line with their global business objectives.

With a cross-border team of professionals who understand the intricacies of navigating international trade laws across jurisdictions, we advise clients on compliance, investigations, and enforcement related to export controls, import and customs laws, tariffs, sanctions, and CFIUS and FDI regulation.

Primary Contacts

If you have any questions or need assistance, please reach out to any of the lawyers pictured below or your regular Morgan Lewis contact.